Basic and Translational Cellular Metabolism in Immunity and Immunological Diseases

Metabolic programming of immune cells is now appreciated to underlie many disease states, including autoimmunity, cancer, allergy, infectious disease, atherosclerosis, neurodegenerative disease, obesity, and diabetes. Metabolic interventions are thus being actively explored in many immunologic diseases. Our understanding of the metabolic wiring of immune cells, however, is still primitive. Moreover, research findings can be sequestered within subfields of immunology, and communications between academia and industry have been limited. To disseminate new findings and promote collaborations we are assembling international experts from academia and industry on the role of cellular metabolism in the programming of myeloid and lymphoid immune cells in immunity and disease. This 2024 conference will address emerging methods, findings, and paradigms. Molecular, cellular, animal, and human data will be presented, aiming to galvanize steps forward in the mechanistic understanding of how cellular metabolism programs immune responses, and how these insights may be therapeutically targeted. We expect to foment productive, high-level discussions and new collaborations, and to create a nurturing and supportive environment for early-career investigators and trainees who represent the next generation of scientists in this critical cross-disciplinary field.